Literature DB >> 8944042

Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.

T A Longacre1, B M Egbert, R V Rouse.   

Abstract

The clinical, histologic, and immunohistologic features of 22 desmoplastic melanomas (DMM), 10 mixed desmoplastic and spindle-cell melanomas (DMM/SMM), and two cellular spindle-cell melanomas (SMM) were studied. Patients ranged in age from 35 to 91 years (mean, 67) and included 23 men and 11 women. Seventeen cases occurred in sun-damaged skin of the head and neck. 11 were on the extremities, and six on the trunk. Except for two cases, all were Clark's level IV or V. Twenty-two (65%) cases were associated with a recognizable overlying pigmented lesion. Thirty of 32 (94%) DMM and DMM/SMM were clearly positive for S100. S100 staining was limited to < 5% of the spindle cells in two DMM/SMM. All DMM were negative when stained with HMB45. Three DMM/ SMM were immunoreactive with HMB45, as were both SMM. CD68 staining was limited to < 5% of the spindle cells in two of 32 DMM and DMM/SMM and 20% of the cells in one of two SMM. Nine (32%) DMM and DMM/SMM contained significant numbers of spindle cells immunoreactive for SMA but not desmin. In five cases, the number of actin-positive spindle cells. Two color stains for SMA and S100 demonstrated that these smooth-muscle actin positive cells constituted a separate spindle-cell population, consistent with reactive myofibroblasts. This study indicates that the immunohistologic features of desmoplastic melanoma differ from those of conventional melanoma. If a problematic spindle-cell skin lesion is a suspected melanocytic process, HMB45 is unlikely to provide confirmatory (or exclusionary) evidence for the diagnosis of DMM. Similarly, because of the variability in S100 expression in this neoplasm, the absence of S100 staining should not be relied on too heavily to exclude DMM if the clinical and histologic features favor that diagnosis. Caution should be exercised in the interpretation of numerous actin-positive spindle cells in isolation of additional confirmatory or exclusionary data as desmoplastic melanomas may contain significant numbers of these cells.

Entities:  

Mesh:

Year:  1996        PMID: 8944042     DOI: 10.1097/00000478-199612000-00008

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.

Authors:  Jodie Barr; Carol M Amato; Steven E Robinson; Nicole Kounalakis; William A Robinson
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

2.  The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).

Authors:  K S Clarkson; I C Sturdgess; A J Molyneux
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 3.  Perivascular epithelioid cell tumors (PEComas) of the head and neck: report of three cases and review of the literature.

Authors:  Anshu Bandhlish; E Leon Barnes; Joseph T Rabban; Jonathan B McHugh
Journal:  Head Neck Pathol       Date:  2011-05-31

4.  Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.

Authors:  Ryan C Romano; Jodi M Carter; Andrew L Folpe
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

5.  Lymph node metastasis of malignant peripheral nerve sheath tumor in the absence of widespread disease five years after diagnosis: a rare finding.

Authors:  Gwendolyn J Godfrey; Hanan Farghaly
Journal:  Int J Clin Exp Pathol       Date:  2010-10-02

6.  High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma.

Authors:  Yasufumi Goto; Takaaki Arigami; Rajmohan Murali; Richard A Scolyer; Atsushi Tanemura; Minoru Takata; Roderick R Turner; Linhda Nguyen; Tung Nguyen; Donald L Morton; Soldano Ferone; Dave S B Hoon
Journal:  Pigment Cell Melanoma Res       Date:  2009-12-04       Impact factor: 4.693

Review 7.  Melanocytic nevi simulant of melanoma with medicolegal relevance.

Authors:  Guido Massi
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

Review 8.  Desmoplastic melanoma: a review.

Authors:  Lucy L Chen; Natalia Jaimes; Christopher A Barker; Klaus J Busam; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2012-12-23       Impact factor: 11.527

9.  A nuclear circularity-based classifier for diagnostic distinction of desmoplastic from spindle cell melanoma in digitized histological images.

Authors:  Manuel Schöchlin; Stephanie E Weissinger; Arnd R Brandes; Markus Herrmann; Peter Möller; Jochen K Lennerz
Journal:  J Pathol Inform       Date:  2014-10-21

Review 10.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.